EPTMF (Epitomee Medical) YoY EBITDA Growth: -205.88% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

EPTMF Epitomee Medical Ltd EPTMF
22 GF Score
Price $0.99
! 3 Warning Signs
View Full Analysis

What is Epitomee Medical YoY EBITDA Growth?

Epitomee Medical EPTMF 22 YoY EBITDA Growth is -205.88% as of Dec. 2025. GuruFocus rates EPTMF with a GF Score™ of 22/100. The stock has 3 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Epitomee Medical's YoY EBITDA Growth for the quarter that ended in Dec. 2025 was -205.88%.

Epitomee Medical's EBITDA per Share for the six months ended in Dec. 2025 was $-0.13.

Epitomee Medical YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Epitomee Medical's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Epitomee Medical YoY EBITDA Growth Chart

Epitomee Medical Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EBITDA Growth
Get a 7-Day Free Trial -4,927.84 89.54 67.06 83.33 -714.29

Epitomee Medical Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 88.36 -13.08 405.13 32.65 -205.88
EPTMF
22GF Score
Epitomee Medical Ltd EPTMF
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Epitomee Medical YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Epitomee Medical's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(-0.228--0.028)/ | -0.028 |
=-714.29 %

Epitomee Medical's YoY EBITDA Growth for the quarter that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (Q: Dec. 2025 )
=(EBITDA per Share (Q: Dec. 2025 )-EBITDA per Share (Q: Dec. 2024 )) / | EBITDA per Share (Q: Dec. 2024 )) |
=(-0.126-0.119)/ | 0.119 |
=-205.88 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of -205.88% mean?
Epitomee Medical (EPTMF) has a YoY EBITDA Growth of -205.88% as of Dec. 2025. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Epitomee Medical and its competitors.
Is Epitomee Medical's YoY EBITDA Growth too high?
Epitomee Medical's current YoY EBITDA Growth is -205.88%. Overall, Epitomee Medical has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Epitomee Medical's YoY EBITDA Growth compare to ABT and SYK?
Epitomee Medical's YoY EBITDA Growth of -205.88% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Medical Devices & Instruments company?
A good YoY EBITDA Growth depends on the Medical Devices & Instruments industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Epitomee Medical and its competitors. Epitomee Medical's current YoY EBITDA Growth is -205.88%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Epitomee Medical stock overvalued right now?
Epitomee Medical (EPTMF) has a current YoY EBITDA Growth of -205.88%. The current YoY EBITDA Growth is -205.88%. Epitomee Medical's overall GF Score™ is 22/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Epitomee Medical (EPTMF), the current YoY EBITDA Growth is -205.88% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Epitomee Medical Business Description

Other Exchanges EPIT:Israel
Address Tarshish 19, Caesarea, ISR, 3088900
Epitomee Medical Ltd is engaged in developing and commercializing ingestible therapeutic devices.
22GF Score

Get the complete analysis for EPTMF

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.99
Price